Olon S.p.A. is a worldwide leader in the development and production of APIs (Active Pharmaceutical Ingredients).
The ideal partner for custom synthesis and contract manufacturing projects.

NEWS & EVENTS

Olon Acquires Manufacturing Facility in India

3 September 2018
Olon announced the acquisition of a local manufacturing facility in Mahad, India.
READ MORE

CPHI Worldwide in Madrid


9-11 October 2018 - Also this year, Olon will be attending the CPHI Worldwide in Madrid. Please visit our booth: 7C10.

ChemOutsourcing in USA


17-19 September 2018
Olon will be attending the ChemOutsourcing in Long Branch, NJ (USA). Please visit our booth: 28.

 

 

Olon on Pharma’s Almanac Magazine


May 2018

Strengthening the outsource service offering through integration...Click the image to read the full article

Olon Announces Investment and Expansion of APIs Manufacturing Capabilities


January 2018

Rodano, Italy – January 26th, 2018 – Between 2016 and 2017, Olon SpA, European leader of API manufacturing, invested more than 10 million € to expand...

READ MORE

OLON acquired RICERCA


June 9th, 2017

OLON SPA (P&R Group) ACQUIRES RICERCA BIOSCIENCES CHEMICAL DIVISION IN OHIO (USA). Acquisition strengthens service offering of global CDMO and Generics provider...

READ MORE
If you need information, speak to one our experts.

FOCUS ON

Recombinant peptides

Olon has developed a recombinant peptide technology that allows to provide its customers with requested peptide on any scale.

Fluorination: a new technology

Olon with its brand new R&D Labs and Reactors for fluorination can now offer a full range of fluorinating processes under cGMP.